Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer.

Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer.

The potential application of multiplexed quantum dot labeling (MQDL) for cancer detection and prognosis and monitoring therapeutic responses has attracted the interests of bioengineers, pathologists and cancer biologists. Many published studies claim that MQDL is effective for cancer biomarker detec...

Full description

Bibliographic Details
Main Authors:	Peizhen Hu, Gina C-Y Chu, Guodong Zhu, Hua Yang, Daniel Luthringer, Gail Prins, Fouad Habib, Yuzhuo Wang, Ruoxiang Wang, Leland W K Chung, Haiyen E Zhau
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3244400?pdf=render

Similar Items

Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study.
by: Peizhen Hu, et al.
Published: (2013-01-01)

Spontaneous cancer-stromal cell fusion as a mechanism of prostate cancer androgen-independent progression.
by: Ruoxiang Wang, et al.
Published: (2012-01-01)

Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells
by: Chen Zhengjia, et al.
Published: (2010-01-01)

Spontaneous Fusion with Transformed Mesenchymal Stromal Cells Results in Complete Heterogeneity in Prostate Cancer Cells
by: Ruoxiang Wang, et al.
Published: (2024-02-01)

Quantum dots-based multiplexed immunohistochemistry of protein expression in human prostate cancer cells
by: C Shi, et al.
Published: (2008-06-01)

The driver role of JAK‐STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy‐ and castration‐resistant prostate cancer
by: U‐Ging Lo, et al.
Published: (2022-08-01)

Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics
by: Gina Chia-Yi Chu, et al.
Published: (2019-01-01)

Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer
by: Yuanyuan Qiao, et al.
Published: (2016-01-01)

Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer.
by: Chen Shao, et al.
Published: (2014-01-01)

A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models
by: Stefan Mrdenovic, et al.
Published: (2023-06-01)

KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway
by: Lijuan Yin, et al.
Published: (2022-01-01)

LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling.
by: Hui-Wen Lue, et al.
Published: (2011-01-01)

Differentiation of human mesenchymal stem cell spheroids under microgravity conditions
by: Wolfgang H Cerwinka, et al.
Published: (2012-01-01)

Near-infrared emitting quantum dots for cellular and vascular fluorescent labeling in in vivo multiplexed imaging studies
by: Wu, Juwell Wendy
Published: (2012)

Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer
by: Stephen Y. C. Choi, et al.
Published: (2022-10-01)

Quantum Dot Nanobeads as Multicolor Labels for Simultaneous Multiplex Immunochromatographic Detection of Four Nitrofuran Metabolites in Aquatic Products
by: Xiuying Liu, et al.
Published: (2022-11-01)

SPINK1 promotes castration resistance in prostate cancer cells
by: I. Madueke, et al.
Published: (2020-07-01)

PDGF upregulates Mcl-1 through activation of β-catenin and HIF-1α-dependent signaling in human prostate cancer cells.
by: Shareen Iqbal, et al.
Published: (2012-01-01)

Cultured circulating tumor cells and their derived xenografts for personalized oncology
by: Ruoxiang Wang, et al.
Published: (2016-10-01)

Inhibition of β2-microglobulin/hemochromatosis enhances radiation sensitivity by induction of iron overload in prostate cancer cells.
by: Sajni Josson, et al.
Published: (2013-01-01)

Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?
by: Magdalena Schrank, et al.
Published: (2020-01-01)

Ultra-bright Raman dots for multiplexed optical imaging
by: Zhilun Zhao, et al.
Published: (2021-02-01)

Multiplex Digital PCR to Detect Amplifications of Specific Androgen Receptor Loci in Cell-Free DNA for Prognosis of Metastatic Castration-Resistant Prostate Cancer
by: Meijun Du, et al.
Published: (2020-08-01)

Biomarkers of Castrate Resistance in Prostate Cancer: Androgen Receptor Amplification and T877A Mutation Detection by Multiplex Droplet Digital PCR
by: Francis P. Young, et al.
Published: (2022-01-01)

Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer
by: Filippos Koinis, et al.
Published: (2020-01-01)

Multiplexed Plasmonic Nano-Labeling for Bioimaging of Cytological Stained Samples
by: Paule Marcoux-Valiquette, et al.
Published: (2021-07-01)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
by: Lixin Mai, et al.
Published: (2020-12-01)

Prognostic significance of time to castration resistance in patients with metastatic castration-sensitive prostate cancer
by: Y. Matsushita, et al.
Published: (2020-07-01)

The role of glutamine metabolism in castration-resistant prostate cancer
by: Bing Zhao, et al.
Published: (2023-01-01)

Multiplexed Spectral Imaging of 120 Different Fluorescent Labels.
by: Alex M Valm, et al.
Published: (2016-01-01)

Quantum dot labeling of mesenchymal stem cells
by: Cascio Wayne E, et al.
Published: (2007-11-01)

miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer
by: Noushin Nabavi, et al.
Published: (2017-06-01)

Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment
by: Guodong Li, et al.
Published: (2023-11-01)

Author Correction: Ultra-bright Raman dots for multiplexed optical imaging
by: Zhilun Zhao, et al.
Published: (2021-04-01)

Enhanced Specificity of Multiplex Polymerase Chain Reaction via CdTe Quantum Dots
by: Liang Gaofeng, et al.
Published: (2011-01-01)

Fluorescence Lifetime Multiplex Imaging in Expansion Microscopy with Tunable Donor–Acceptor Polymer Dots
by: Jie Liu, et al.
Published: (2023-06-01)

Time to Castration Resistance as a Predictor of Response to Docetaxel in Metastatic Castration Resistance in Prostate Cancer
by: İlkay Gültürk, et al.
Published: (2022-11-01)

Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC)
by: Yan Li, et al.
Published: (2022-10-01)

Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer
by: Mahasha P.J. Perera, et al.
Published: (2022-01-01)

Responsive Janus Structural Color Hydrogel Micromotors for Label-Free Multiplex Assays
by: Huan Wang, et al.
Published: (2021-01-01)